HL SELECT UK INCOME SHARES

Income Reshuffle

Fund changes

Important information - The value of this fund can still fall so you could get back less than you invested, especially over the short term. The information shown is not personal advice and the information about individual companies represents our view as managers of the fund. It is not a personal recommendation to invest in a particular company. If you are at all unsure of the suitability of an investment for your circumstances please contact us for personal advice. The HL Select Funds are managed by our sister company HL Fund Managers Ltd.

Steve Clayton - Fund Manager

25 January 2018

We have been making some changes within the HL Select UK Income Shares portfolio. Our aim is to raise the growth rate of the portfolio’s holdings, whilst diversifying the sources of income. We have trimmed some holdings and introduced a few new names, taking the number of holdings to just over 30.

We have trimmed the position in GlaxoSmithKline (GSK) and introduced a holding in Royal Dutch Shell. Dividend prospects for the latter have improved significantly as a result of a major programme of cost-cutting and rising production volumes.

Why we bought Royal Dutch Shell

Like other oil producers, Shell’s earnings were hit when oil prices fell in 2014. The company responded by aggressively cutting costs and also bringing new, low cost production assets into the group through a merger with BG Group. This has left the group much more strongly cash generative and reinforced Shell’s dividend-paying capabilities.

Historically, Shell has an unparalleled track record for paying its dividend through thick and thin, having maintained or increased it every year since the end of the Second World War. Although, of course, dividends and yields are variable and not guaranteed.

GSK trimmed

We see emerging risks around GSK’s dividend. The Board has stated an intention to continue paying 80p per share in 2018, but has made no commitments beyond then. GSK’s newish CEO has come from the Consumer Healthcare division, and there are major asset packages up for sale in that sector. If GSK decide to pursue major deal-making, they may well need equity to fund it and the current dividend cost would be a major hurdle to clear.

Elsewhere, we’ve taken some profits out of the holding in Sage Group, but retain a significant position. National Grid gets a haircut too, as we bring down our utility exposure in the face of rising regulatory pressure on pricing and an unhelpful political environment.

New positions being built

New names are coming in to the portfolio, with an emphasis on stocks capable of strong dividend growth, ahead of absolute yield. These positions are still in the process of being built up, and will not be revealed until complete. Some should complete in the next week, others could take longer.

One new holding, for instance, is almost 90% complete, but finding the remaining stock, at the price we want to pay, rather than the price that a seller might wish to receive, is easier said than done.

We’ve taken a variety of strategies to cover the dealing necessary to achieve the desired positions. In larger, more liquid names we’ve been able to use programme trading, where a broker is instructed to deal in a basket of stocks simultaneously for an extremely low rate of commission.

Smaller and medium sized companies are higher risk and often harder to trade. Here we select individual brokers to handle each order, with precise instructions as to the strategy they should adopt. Cash has to be balanced throughout, with sales and purchases kept in balance to avoid excess cash building up or dipping into an overdrawn position.

The fund’s financial year runs to Sep 30 2018 and we expect to continue declaring dividends of 0.3p per month through until August, with a variable payment for the September month, reflecting any special dividends or other income received but not already paid out by the fund.

Please remember that a dividend declared for any given month is actually paid to investors at the end of the following month. If you hold Accumulation units in the fund, then these dividends are rolled up into the value of your units. That is why the price of Accumulation units is higher than those of Income units in the fund.

View portfolio breakdown

More about HL Select UK Income Shares

Non-Independent Research Disclosure

The information on this website is not intended to be advice or a recommendation to buy, sell or hold any investment mentioned. No view is given as to the present or future value or price of any investment, and investors should form their own view in relation to any proposed investment.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.

The research material provided on our website is not an offer to buy or sell any of the stocks mentioned. Hargreaves Lansdown accepts no responsibility for any use made of these comments and for any consequences that may result. We cannot guarantee the accuracy or completeness of the information provided and consideration has not been given to the personal circumstances of any investor. Therefore any person acting on it does so entirely at their own risk and must assess the suitability of any investment for their own personal circumstances and individual investment objectives. It is not a personal recommendation.

Although we are not specifically constrained from dealing ahead of any research material we do not seek to take advantage of it before it is provided to our clients. We aim to establish and maintain and operate effective organisational and administrative arrangements with a view to taking all reasonable steps to prevent conflicts of interest from constituting or giving rise to a material risk of damage to the interests of our clients (including restrictions on dealing for writers of equity commentary).

Hargreaves Lansdown Fund Managers Ltd (HLFM) manages funds that may hold investments which are the subject of commentary prepared and published by other parts of the Hargreaves Lansdown group. Accordingly, appropriate organisational and administrative controls (including physical and information barriers, known as “Chinese Walls”) are in place between different parts of our business, including our marketing and fund management functions, in order to manage these potential conflicts of interest. For more information please see our Conflicts of Interest policy. HLFM currently manages three funds which hold individual equity securities. Details of the significant shareholdings held by these funds can be found here for the HL Select UK Growth Shares fund, here for the HL Select UK Income Shares fund and here for the HL Select Global Growth Shares fund. Hargreaves Lansdown (Nominees) Limited holds individual securities as nominee on behalf of underlying clients of Hargreaves Lansdown, and does not exercise control over or hold the beneficial ownership of these securities.

We do not intend to provide recommendations to buy, sell or hold particular investments, nor do we provide price targets. Our opinions on particular investments (and the facts underlying them) are valid as at the date of publication, but can change at any time, and we may not update our views on any particular investment on a regular basis. Accordingly such opinions and facts may become outdated or obsolete after the date of publication.

Issued by Hargreaves Lansdown Asset Management Limited, which is authorised and regulated by the Financial Conduct Authority (FCA Register number 115248, see FCA register for registration details) and registered in England and Wales No 1896481. Registered office: 1 College Square South, Anchor Road, Bristol BS1 5HL.

for more information. Unless otherwise stated performance figures are from Bloomberg and estimates, including prospective yields, are a consensus of analyst forecasts from Bloomberg. They are not a reliable indicator of future performance. Yields are variable and not guaranteed.